Department of Respiratory and Critical Care Medicine, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, China.
BMC Pulm Med. 2021 Mar 1;21(1):73. doi: 10.1186/s12890-021-01434-5.
Scarring central airway stenosis (SCAS) is a potentially life-threatening condition with debilitating symptoms. Interventional bronchoscopy is increasingly used to relieve symptoms in patients with SCAS, but recurrent stenosis is frequently observed. Little data exist on the long-term prognosis of interventional bronchoscopy for SCAS. We aimed to assess the prognostic factors of bronchoscopic interventions in patients with SCAS to optimize treatment.
This was a retrospective study that enrolled 119 consecutive patients with SCAS from January 2010 to April 2019 at our institution. Long-term clinical success was defined as airway stenosis < 50%, no limitation of physical activity, and a stable condition for > 12 months after the last interventional procedure. We compared patients' demographics, airway stenosis characteristics, and interventional procedures between the successful and unsuccessful groups, and identified significant predictors of long-term outcome with univariate and multivariate logistic regression.
A total of 119 patients with 577 therapeutic bronchoscopies were included. Seventy-five (63%) patients were considered to have long-term clinical success. Older age, male gender, smoking, elevated C-reactive protein level, subglottic stenosis, stent or T-tube implantation, previous interventional treatment, and multiple procedures per year were potentially associated with unsuccessful long-term outcomes in the univariate analysis. Current smoker status (odds ratio [OR] 5.70, 95% confidence interval [CI] 1.35-24.17, P = 0.018), subglottic stenosis (OR 4.35, 95% CI 1.31-14.46, P = 0.017), and stent implantation (OR 4.96, 95% CI 1.33-18.48, P = 0.017) were associated with decreased odds of long-term success in the multivariate logistic regression analysis. Of note, there was no significant difference in odds of success between former smokers and nonsmokers.
Current smoker status, subglottic stenosis, and stent implantation are independent factors associated with reduced long-term efficacy of interventional bronchoscopy for SCAS. Smoking cessation should be encouraged to improve the outcome of therapeutic bronchoscopy.
瘢痕性中央气道狭窄(SCAS)是一种潜在的危及生命的疾病,会导致衰弱性症状。介入性支气管镜检查越来越多地用于缓解 SCAS 患者的症状,但经常观察到复发性狭窄。关于介入性支气管镜治疗 SCAS 的长期预后的数据很少。我们旨在评估 SCAS 患者支气管镜介入治疗的预后因素,以优化治疗。
这是一项回顾性研究,纳入了 2010 年 1 月至 2019 年 4 月期间我院 119 例连续的 SCAS 患者。长期临床成功定义为气道狭窄 < 50%,体力活动不受限制,最后一次介入治疗后 12 个月以上病情稳定。我们比较了成功组和失败组患者的人口统计学、气道狭窄特征和介入程序,并通过单因素和多因素逻辑回归确定了长期结果的显著预测因素。
共纳入 119 例患者,共进行了 577 次治疗性支气管镜检查。75 例(63%)患者被认为具有长期临床成功。年龄较大、男性、吸烟、C 反应蛋白水平升高、声门下狭窄、支架或 T 型管植入、既往介入治疗和每年多次手术在单因素分析中与长期预后不良相关。当前吸烟状态(比值比 [OR] 5.70,95%置信区间 [CI] 1.35-24.17,P = 0.018)、声门下狭窄(OR 4.35,95%CI 1.31-14.46,P = 0.017)和支架植入(OR 4.96,95%CI 1.33-18.48,P = 0.017)与多因素逻辑回归分析中的长期成功几率降低相关。值得注意的是,前吸烟者和非吸烟者之间成功几率无显著差异。
当前吸烟状态、声门下狭窄和支架植入是与介入性支气管镜治疗 SCAS 长期疗效降低相关的独立因素。应鼓励戒烟以改善治疗性支气管镜的疗效。